Pursuant to Regulation 29 and 50 of the Listing Regulations, Piramal Pharma has informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 24th May, 2023, to consider the Audited Financial Results (Standalone and Consolidated) of the Company for the financial year ended 31st March, 2023. In this regard, the ‘Trading Window’ for dealing in the securities of the Company, which has been closed from Saturday 01st April, 2023 will remain closed till Friday, 26th May, 2023.
The above information is a part of company’s filings submitted to BSE.
